# Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure

> **NCT00347087** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 36 (actual)

## Conditions studied

- Chronic Heart Failure

## Interventions

- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT00347087
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2007-10-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00347087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00347087, "Effect of Irbesartan on Insulin Sensitivity in Chronic Heart Failure". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT00347087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*